SANA develops engineered cell therapies for diabetes, autoimmune diseases, and cancer using ex vivo HIP and in vivo fusogen platforms. SC291 is their CD19‑targeted allogeneic CAR-T candidate which ...

FBT selects 30 biotechnology stocks based on sales, sales as a percentage of R&D expenditures, and R&D growth compared to three years ago. The ETF launched 19 years ago and has delivered exceptional ...

The biotech world is a prime target for risk-tolerant investors seeking out companies with the potential for dramatic gains. Firms in this space often either make it big—spiking upon news of a ...

A Phase 3 trial of a targeted drug developed by Merck and China’s Kelun-Biotech cut by one-third the risk of death in ...

US GDP growth running at a 3.4% annual pace puts risk assets back in focus, and that includes Canadian biotech stocks that ...

Insider buying matters in every industry, but it carries a special weight in biotechnology. In most businesses, management has a reasonably clear view of sales trends, margins, customer demand, and ...

GATC Health has launched a new AI-driven platform designed to help biotech companies, investors, and insurers assess the risk of drug candidates before entering clinical trials. The tool, called ...

It's normal for biotechs to buy intellectual property. It can be risky for a company to underinvest in its own R&D capabilities. 10 stocks we like better than Summit Therapeutics › For most of the ...

A little?known Warsaw-listed biotech just posted fresh data and a new cash runway. Here is why Captor Therapeutics is suddenly on global watchlists—and what US investors need to weigh before jumping ...

For most of the past three decades, U.S.-listed biotech companies were fair proxies for homemade American science. But now, that assumption is fraying. By one estimate from investment bank Jefferies, ...

Biotech stocks have a way of making smart people do dumb things. It starts innocently enough. You read about a "breakthrough" that sounds like it came straight out of science fiction. A tiny company ...